DY
CELG

Dowling & Yahnke’s Celgene Corp CELG Stock Holding History

Dowling & Yahnke’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-25,435
Closed -$2.53M – 390
2019
Q3 		$2.53M Buy
25,435
+1,031
+4% +$98K 0.21% 126
2019
Q2 		$2.26M Buy
24,404
+6,115
+33% +$581K 0.19% 135
2019
Q1 		$1.73M Sell
18,289
-6,350
-26% -$555K 0.17% 134
2018
Q4 		$1.78M Sell
24,639
-9,743
-28% -$719K 0.18% 126
2018
Q3 		$3.08M Sell
34,382
-9,804
-22% -$866K 0.27% 107
2018
Q2 		$3.51M Buy
44,186
+15,338
+53% +$1.27M 0.33% 98
2018
Q1 		$2.57M Sell
28,848
-5,269
-15% -$506K 0.24% 119
2017
Q4 		$3.56M Buy
34,117
+6,760
+25% +$763K 0.32% 95
2017
Q3 		$3.99M Buy
27,357
+285
+1% +$38.8K 0.4% 84
2017
Q2 		$3.52M Buy
27,072
+155
+0.6% +$19K 0.37% 90
2017
Q1 		$3.35M Buy
26,917
+913
+4% +$109K 0.36% 94
2016
Q4 		$3.01M Buy
26,004
+490
+2% +$54.6K 0.34% 100
2016
Q3 		$2.67M Buy
25,514
+828
+3% +$89.6K 0.31% 105
2016
Q2 		$2.44M Buy
24,686
+3,122
+14% +$323K 0.29% 108
2016
Q1 		$2.16M Buy
21,564
+2,324
+12% +$239K 0.27% 110
2015
Q4 		$2.3M Buy
19,240
+30
+0.2% +$3.47K 0.29% 107
2015
Q3 		$2.08M Buy
19,210
+937
+5% +$116K 0.28% 107
2015
Q2 		$2.12M Sell
18,273
-438
-2% -$50.1K 0.27% 111
2015
Q1 		$2.16M Sell
18,711
-126
-0.7% -$15.1K 0.27% 111
2014
Q4 		$2.11M Buy
18,837
+1,284
+7% +$135K 0.26% 109
2014
Q3 		$1.66M Buy
17,553
+45
+0.3% +$4.06K 0.22% 124
2014
Q2 		$1.5M Buy
17,508
+1,050
+6% +$79.8K 0.19% 133
2014
Q1 		$1.15M Buy
16,458
+1,050
+7% +$83.2K 0.15% 142
2013
Q4 		$1.3M Buy
15,408
+1,280
+9% +$101K 0.18% 128
2013
Q3 		$1.09M Buy
14,128
+604
+4% +$42.3K 0.17% 132
2013
Q2 		$791K Buy
+13,524
New +$814K 0.13% 142

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Dowling & Yahnke's CELG Position: Q4 2019 in Review

Dowling & Yahnke sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 25,435 shares — an estimated $2.53M sold.

Dowling & Yahnke first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $3.99M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Dowling & Yahnke reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Dowling & Yahnke sold 25,435 Celgene Corp shares in Q4 2019, an estimated $2.53M.
  • Dowling & Yahnke first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Dowling & Yahnke's Celgene Corp position peaked at $3.99M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Dowling & Yahnke's 13F filing for Q4 2019, filed 27 Jan 2020.